• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Antidepressant use during pregnancy linked to increased NICU admittance

bySara RubinandCordelia Ross
October 25, 2016
in Obstetrics, Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Neonatal intensive care unit (NICU) admittance was higher among infants born to women receiving selective serotonin reuptake inhibitors (SSRIs) during pregnancy compared to nonexposed infants.

2. Maternal SSRI use during late pregnancy was associated with an increase in infant respiratory and CNS-related disorders, hypoglycemia, and feeding difficulties compared to SSRI use limited to early- and mid-pregnancy.

Evidence Rating Level: 2 (Good)

Study Rundown: SSRIs, including fluoxetine (Prozac) and sertraline (Zoloft), are commonly prescribed antidepressants. The consequences of untreated psychiatric illness during pregnancy are often thought to outweigh the risks of SSRI use; thus, SSRIs currently are not contraindicated during pregnancy. However, maternal SSRI use has been linked to several neonatal complications, including hypoglycemia, jaundice, and persistent pulmonary hypertension of the newborn. To investigate the severity of such complications and to tease apart the influence of SSRIs versus that of psychiatric illness, researchers performed a register-based analysis of singleton births in Sweden. Using NICU admission as a surrogate for severity of neonatal complications, results suggested that any use of SSRIs was associated with an increase in neonatal complications. With regard to neonatal morbidity, the authors were particularly interested in two comparisons: SSRI-exposure vs. no exposure and SSRI-exposure occurring within the last 90 days of pregnancy (late) vs. SSRI-exposure ceasing before that time period. Adjusted data were consistent with increased respiratory and CNS-related disorders and hypoglycemia with any SSRI exposure, with an additional increase in feeding difficulties for late SSRI use compared to early use only. Limitations of this study included its lack of accounting for severity of maternal illness and actual SSRI exposure, as prescriptions of SSRIs do not necessarily correspond to use. However, in the context of other reports consistent with these findings, clinicians may wish to reweigh the costs and benefits of continuing or initiating SSRIs in the 3rd trimester of pregnancy.

Click to read the study, published today in Pediatrics

Relevant Reading: Use of selective serotonin reuptake inhibitors during pregnancy

Study Author, Ulrika Nörby, MSc Pharm talks to 2 Minute Medicine: Department of E-health and Strategic IT, Health and Medical Care Administration, Stockholm County Council, Stockholm, Sweden.

RELATED REPORTS

Meditation may provide medical benefit for various health outcomes

Spiritual interventions may be associated with improved psychological and spiritual outcomes

Wellness Check: Spirituality

“Newborn infants exposed to antidepressant drugs in utero had more complications and a higher rate of admissions to a NICU, in this large population-based study providing detailed information on neonatal diagnoses and interventions. The risk for severe neonatal illness was however low and should not prevent necessary treatment of depression and anxiety during pregnancy.”

In-Depth [retrospective cohort]: The Swedish Medical Birth Register and the Prescribed Drug Register for all singleton births in Sweden between July 1, 2006 and December 31, 2012 were used to divide the study population into 4 main groups: infants born to mothers receiving SSRIs at any time during or 1 month prior to pregnancy (any use), those born to mothers receiving SSRIs within the last 90 days of pregnancy with or without prior use (late use), those born to mothers only receiving SSRIs up until that time period (early use only), and those not listed (no use). Antidepressant use more broadly was also recorded. This information was linked to data on NICU admissions and neonatal diagnoses in the Swedish Neonatal Quality Register and Perinatal Revision South Register. In total, >700,000 births were included for analysis. After adjusting for maternal factors (e.g., maternal age and smoking habits) and fetal factors (gestational age [GA] and fetal weight for GA and sex), the odds ratio (OR) of NICU admission for any SSRI use was 1.5 (95% CI 1.4-1.5) relative to no antidepressant use. Comparing the neonatal outcomes between the early use only and late use groups suggested that SSRI use in the final 90 days of pregnancy increased the odds of infant respiratory and CNS-related disorders (OR 95% CIs: 1.2-1.6 and 1.2-3.0, respectively), hypoglycemia (OR 95% CI: 1.1-1.6), and feeding difficulties (OR 95% CI: 1.1-1.9). Although the analysis primarily focused on SSRIs, different classes of antidepressant medications were found to carry different risks for NICU admission.

Image: CC

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antidepressantsanxietydepressionSSRI
Previous Post

Updated recommendations for safe infant sleeping to reduce SIDS risk

Next Post

Tobacco-related cancer deaths in the US disproportionately affects Southern states

RelatedReports

Quick Take: Intimate Partner Homicide of Adolescents
Chronic Disease

Meditation may provide medical benefit for various health outcomes

May 17, 2022
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

Spiritual interventions may be associated with improved psychological and spiritual outcomes

May 13, 2022
Wellness

Wellness Check: Spirituality

May 12, 2022
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Infectious Disease

COVID-19 pandemic associated with worsening psychological distress across United Kingdom cohort studies

April 29, 2022
Next Post
Smoking during pregnancy associated with aerobic fitness of children

Tobacco-related cancer deaths in the US disproportionately affects Southern states

AAP recommends disaster preparedness measures for children

Children with persistent post-concussion symptoms have a lower quality of life

Five risk factors linked to half of preventable cardiovascular deaths

Long-term oxygen not linked with improved mortality in moderate COPD: The LOTT trial

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.